Sponsor:
Janssen Pharmaceutica N.V., Belgium
Code:
NCT06544616
Conditions
Preclinical Alzheimer's Disease
Eligibility Criteria
Sex: All
Age: 55 - 70+
Healthy Volunteers: Not accepted
Interventions
JNJ-64042056
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Janssen Pharmaceutica N.V., Belgium on 2025-05-23.